Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Works of Remus Vezan being referenced
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia
2022
Abstract CT055: Phase 1/2 primary analysis of ZUMA-6: Axicabtagene ciloleucel (Axi-Cel) in combination With atezolizumab (Atezo) for the treatment of patients (Pts) with refractory diffuse large B cell lymphoma (DLBCL)
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Remus Vezan | 157 | 24 | 29 | 92 | 63 | 16 | 229 | |
| Kathleen Ruehle | 206 | 17 | 119 | 77 | 40 | 24 | 280 | |
| David M. Cordas dos Santos | 219 | 12 | 47 | 72 | 25 | 16 | 268 | |
| Patricia Steinert | 173 | 36 | 85 | 48 | 24 | 19 | 243 | |
| Patrycja Wawrzyniecka | 228 | 42 | 17 | 72 | 85 | 16 | 291 | |
| Marion Subklewe | 197 | 11 | 61 | 66 | 24 | 23 | 232 | |
| Paolo Strati | 146 | 4 | 31 | 33 | 64 | 20 | 198 | |
| Alex H. Chang | 241 | 30 | 35 | 61 | 24 | 23 | 273 | |
| Ira L. Kraft | 126 | 33 | 99 | 72 | 19 | 19 | 277 | |
| Jaquelyn T. Zoine | 186 | 13 | 21 | 76 | 17 | 12 | 248 | |
| Anna Truppel-Hartmann | 218 | 6 | 126 | 140 | 51 | 22 | 279 |
All Works
Loading papers...